Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma
Yoon Soo Chang, Chang-Min Choi, Jae Cheol Lee
Tuberc Respir Dis. 2016;79(4):248-256.   Published online 2016 Oct 5     DOI: https://doi.org/10.4046/trd.2016.79.4.248
Citations to this article as recorded by Crossref logo
New Targeted Therapy for Non-Small Cell Lung Cancer
Eun Ki Chung, Seung Hyun Yong, Eun Hye Lee, Eun Young Kim, Yoon Soo Chang, Sang Hoon Lee
Tuberculosis and Respiratory Diseases.2023; 86(1): 1.     CrossRef
New targeted therapies for non-small cell lung cancer
Eun Hye Lee, Se Hyun Kwak, Chi Young Kim, Hye Ran Gwon, Eun Young Kim, Yoon Soo Chang
Journal of the Korean Medical Association.2023; 66(3): 180.     CrossRef
Optimization of Pharmacophore of Novel Hybrid Nucleus of 1,3,4- oxadiazole-chalcone using Literature Findings and In silico Approach as EGFR Inhibitor
Shital M. Patil, Shashikant V. Bhandari
Letters in Drug Design & Discovery.2023; 20(6): 779.     CrossRef
EGFR-T790M Mutation–Derived Interactome Rerouted EGFR Translocation Contributing to Gefitinib Resistance in Non-Small Cell Lung Cancer
Pei-Shan Wu, Miao-Hsia Lin, Jye-Chian Hsiao, Pei-Yi Lin, Szu-Hua Pan, Yu-Ju Chen
Molecular & Cellular Proteomics.2023; 22(9): 100624.     CrossRef
Novel biomolecules in targeted cancer therapy: a new approach towards precision medicine
Sandra Kannampuzha, Reshma Murali, Abilash Valsala Gopalakrishnan, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Arunraj Namachivayam, Alex George, Abhijit Dey, Balachandar Vellingiri
Medical Oncology.2023;[Epub]     CrossRef
A pharmacological exploration of targeted drug therapy in non-small cell lung cancer
Ajay P. Jayan, K. R. Anandu, Krishnadas Madhu, V. N. Saiprabha
Medical Oncology.2022;[Epub]     CrossRef
Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections
Cathleen R. Carlin
Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
Pretreatment Neutrophil-to-Lymphocyte Ratio and Smoking History as Prognostic Factors in Advanced Non–Small Cell Lung Cancer Patients Treated with Osimertinib
Ji Young Park, Seung Hun Jang, Chang Youl Lee, Taehee Kim, Soo Jie Chung, Ye Jin Lee, Hwan Il Kim, Joo-Hee Kim, Sunghoon Park, Yong Il Hwang, Ki-Suck Jung
Tuberculosis and Respiratory Diseases.2022; 85(2): 155.     CrossRef
Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule
Bashir Lawal, Alexander T. H. Wu, Hsu-Shan Huang
Frontiers in Immunology.2022;[Epub]     CrossRef
A Review: Discovering 1,3,4-oxadiazole and Chalcone Nucleus for Cytotoxicity / EGFR Inhibitory Anticancer Activity
Shital Patil, Shashikant Bhandari
Mini-Reviews in Medicinal Chemistry.2022; 22(5): 805.     CrossRef
High Tumor Mutation Burden Is Associated with Poor Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy
Ji-Youn Sung, Dong-Won Park, Seung-Hyeun Lee
Biomedicines.2022; 10(9): 2109.     CrossRef
Structural insights into conformational stability and binding of thiazolo-[2,3-b] quinazolinone derivatives with EGFR-TKD and in-vitro study
Showkat Ahmad Mir, Prajna Paramita Mohanta, Rajesh Kumar Meher, Iswar baitharu, Mukesh Kumar Raval, Ajaya Kumar Behera, Binata Nayak
Saudi Journal of Biological Sciences.2022; 29(12): 103478.     CrossRef
Development of an LC–MS/MS method for quantifying ASK120067, a novel mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) as well as its main metabolite in human plasma and its application in a pharmacokinetic study
Xinge Cui, Shaoyuan Wang, Huitao Gao, Baolan Li, Yuankai Shi, Haifang Guo, Tingting Song, Xin Zheng
Journal of Chromatography B.2021; 1162: 122488.     CrossRef
MiR-328–3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1
Jiancong Lu, Junhong Lin, Yu Zhou, Kai Ye, Changquan Fang
Biochemical and Biophysical Research Communications.2021; 550: 99.     CrossRef
miR-199a-3p plays an anti-tumorigenic role in lung adenocarcinoma by suppressing anterior gradient 2
Hui Liu, Yanfeng Wang, Yi Wang, Daoyuan Wu, He Zhang
Bioengineered.2021; 12(1): 7859.     CrossRef
Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy
Won Gun Kwack, Ji-Youn Sung, Seung Hyeun Lee
Frontiers in Oncology.2021;[Epub]     CrossRef
Gene microarray expression profile analysis of differentially expressed genes of potential alternative pathways in non–small cell lung cancer: In search of biomarkers
Umadevi Bommu, Kranthi Kumar Konidala, Neeraja Pabbaraju, Suneetha Yeguvapalli
Gene Reports.2020; 19: 100633.     CrossRef
Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation
Sang Hoon Lee, Eun Young Kim, Arum Kim, Yoon Soo Chang
Cancer Biology & Therapy.2020; 21(8): 741.     CrossRef

Diagnostic and Predictive Values of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma

Il Ki Hong, Jeong Mi Lee, In Kyoung Hwang, Seung Sook Paik, Chanwoo Kim, Seung Hyeun Lee
Cancer Management and Research.2020; Volume 12: 6453.     CrossRef
Clinical implementation of plasma EGFR T790M testing using droplet digital PCR in TKI-resistant NSCLC patients
Dana Leng Hui Chan, Grace Li Xian Toh, Liuh Ling Goh
Experimental and Molecular Pathology.2020; 116: 104515.     CrossRef

High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy

Byung Woo Yoon, Boksoon Chang, Seung Hyeun Lee
OncoTargets and Therapy.2020; Volume 13: 8273.     CrossRef
Design, synthesis and biological evaluation of novel heptamethine cyanine dye-erlotinib conjugates as antitumor agents
Xiaoguang Yang, Zhuang Hou, Dun Wang, Yanhua Mou, Chun Guo
Bioorganic & Medicinal Chemistry Letters.2020; 30(23): 127557.     CrossRef
Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma
Taehee Kim, Eun Young Kim, Sang Hoon Lee, Do Sun Kwon, Arum Kim, Yoon Soo Chang
Thoracic Cancer.2019; 10(12): 2267.     CrossRef
Mobile Phone App–Based Pulmonary Rehabilitation for Chemotherapy-Treated Patients With Advanced Lung Cancer: Pilot Study
Sojung Park, Ji Youn Kim, Jae Cheol Lee, Hyeong Ryul Kim, Seungjae Song, Hee Kwon, Wonjun Ji, Chang Min Choi
JMIR mHealth and uHealth.2019; 7(2): e11094.     CrossRef
Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice
Dong Kyu Oh, Won Jun Ji, Woo Sung Kim, Chang-Min Choi, Shin-Kyo Yoon, Jin Kyung Rho, Jae Cheol Lee, Jung Weon Lee
PLOS ONE.2019; 14(1): e0210225.     CrossRef
Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma
In Kyoung Hwang, Seung Sook Paik, Seung Hyeun Lee
Cancer Research and Treatment.2019; 51(1): 158.     CrossRef
Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer
Eun Young Kim, Jin Gu Lee, Jung Mo Lee, Arum Kim, Hee Chan Yoo, Kibum Kim, Minji Lee, Chulho Lee, Gyoonhee Han, Jung Min Han, Yoon Soo Chang
Therapeutic Advances in Medical Oncology.2019; 11: 175883591984679.     CrossRef
Targeting Epidermal Growth Factor Receptor in Non-Small-Cell-Lung Cancer: Current State and Future Perspective
Shui-Ming Bao, Qing-Hui Hu, Wen-Ting Yang, Yao Wang, Yin-Ping Tong, Wen-Dai Bao
Anti-Cancer Agents in Medicinal Chemistry.2019; 19(8): 984.     CrossRef
Long non‑coding RNAs in lung cancer: Regulation patterns, biologic function and diagnosis implications (Review)
Lin Jiang, Zheng Li, Ranran Wang
International Journal of Oncology.2019;[Epub]     CrossRef
Discovery of a Potent and Mutant-Selective EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Lung Cancer
Dong Ha Kim, Yun Jung Choi, Seon Ye Kim, Jung-Eun Lee, Ki Jung Sung, Young Hoon Sung, Woo Sung Kim, Sung-Eun Kim, Hyung Chul Ryu, Jae Sun Kim, Lu Guangying, Chang-Min Choi, Jin Kyung Rho, Jae Cheol Lee
Targeted Oncology.2018; 13(3): 389.     CrossRef
Aberrant expression of hsa_circ_0025036 in lung adenocarcinoma and its potential roles in regulating cell proliferation and apoptosis
Shujun Wu, Hui Li, Chunya Lu, Furui Zhang, Huaqi Wang, Xinhua Lu, Guojun Zhang
Biological Chemistry.2018; 399(12): 1457.     CrossRef
Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis
Seung Sook Paik, In Kyoung Hwang, Myung Jae Park, Seung Hyeun Lee
Tuberculosis and Respiratory Diseases.2018; 81(2): 148.     CrossRef
Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
Eun Young Kim, Arum Kim, Gaeun Lee, Hangsuck Lee, Yoon Soo Chang
BMC Cancer.2018;[Epub]     CrossRef
Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015
Chang Dong Yeo, Myoung Kyu Lee, Seung Hyeun Lee, Eun Young Kim, Ik Jae Lee, Heae Surng Park, Yoon Soo Chang
Tuberculosis and Respiratory Diseases.2018; 81(1): 19.     CrossRef
Correlation between progression‐free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced‐stage EGFR‐mutated non‐small cell lung cancer
Yunkyoung Lee, Sojung Park, Woo Sung Kim, Jae Cheol Lee, Se Jin Jang, Jene Choi, Chang‐Min Choi
Thoracic Cancer.2018; 9(9): 1104.     CrossRef